Land: Cypern
Språk: grekiska
Källa: Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας
ATENOLOL
DELORBIS PHARMACEUTICALS LTD (0000009620) 17 ATHINON STREET, ERGATES INDUSTRIAL AREA, LEFKOSIA, 2081, 28629
C07AB03
ATENOLOL
50MG
TABLETS
ATENOLOL (0029122687) 50MG
ORAL USE
Εθνική Διαδικασία
ATENOLOL
Νομικό καθεστώς: Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 20 TABS IN BLISTER(S) (930046801) 20 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται; PACK WITH 30 TABS IN BLISTER(S) (930046802) 30 TABLET - Εγκεκριμένο - Με Ιατρική Συνταγή που Επαναλαμβάνεται
COMPARATIVE TABLE OF PIL-EN VS PIL-GR PACKAGE LEAFLET: INFORMATION FOR THE PATIENT TREDOL 25 MG TABLETS TREDOL 50 MG TABLETS TREDOL 100 MG TABLETS Atenolol READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Tredol is and what it is used for 2. What you need to know before you take Tredol 3. How to take Tredol 4. Possible side effects 5. How to store Tredol 6. Contents of the pack and other information 1. WHAT TREDOL IS AND WHAT IT IS USED FOR ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ: ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΤΟΝ ΑΣΘΕΝΉ TREDOL 25 MG ΔΙΣΚΊΑ TREDOL 50 MG ΔΙΣΚΊΑ TREDOL 100 MG ΔΙΣΚΊΑ Ατενολόλη ΔΙΑΒΆΣΤΕ ΠΡΟΣΕΚΤΙΚΆ ΟΛΌΚΛΗΡΟ ΤΟ ΦΎΛΛΟ ΟΔΗΓΙΏΝ ΧΡΉΣΗΣ ΠΡΙΝ ΑΡΧΊΣΕΤΕ ΝΑ ΠΑΊΡΝΕΤΕ ΑΥΤΌ ΤΟ ΦΆΡΜΑΚΟ, ΔΙΌΤΙ ΠΕΡΙΛΑΜΒΆΝΕΙ ΣΗΜΑΝΤΙΚΈΣ ΠΛΗΡΟΦΟΡΊΕΣ ΓΙΑ ΣΑΣ. Φυλάξτε αυτό το φύλλο οδηγιών χρήσης. Ίσως χρειαστεί να το διαβάσετε ξανά. Εάν έχετε περαιτέρω απορίες, ρωτήστε το γιατρό ή το φαρμακοποιό σας. Η συνταγή για αυτό το φάρμακο χορηγήθηκε αποκλειστικά για σας. Δεν πρέπει να δώσετε το φάρμακο σε άλλους. Μπορεί να τους προκαλέσει βλάβη, ακόμα και όταν τα σημεία της ασθένειάς τους ε Läs hela dokumentet
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICAL PRODUCT Tredol 25 mg Tablets Tredol 50 mg Tablets Tredol 100 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION For 25 mg strength: Each tablet contains 25 mg atenolol. For 50 mg strength: Each tablet contains 50 mg atenolol. For 100 mg strength: Each tablet contains 100 mg atenolol. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablets. Tredol 25 mg: White, flat, round tablets, 8mm diameter in size, cross-scored on one side. Tredol 50 mg: White, concave, round tablets, 9mm diameter in size, scored on one side. Tredol 100 mg: White, flat, round tablets, 12mm diameter in size, scored on one side. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Tredol is indicated in the treatment of: • Management of hypertension. • Management of angina pectoris. • Management of cardiac arrhythmias. • Management of myocardial infarction. Early intervention in the acute phase. 1 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY The dose must always be adjusted to individual requirements of the patients, with the lowest possible starting dosage. The following are guidelines: ADULTS HYPERTENSION One tablet daily. Most patients respond to 100 mg daily given orally as a single dose. Some patients, however, will respond to 50 mg given as a single daily dose. The effect will be fully established after one to two weeks. Α further reduction in blood pressure may be achieved by combining atenolol with other antihypertensive agents. For example, co-administration of atenolol with a diuretic, as in Atenolol/Chlortalidone, provides a highly effective and convenient antihypertensive therapy. ANGINA Most patients with angina pectoris will respond to 100 mg given orally once daily or 50 mg given twice daily. It is unlikely that additional benefit will be gained by increasing the dose. CARDIAC ARRHYTHMIAS A suitable initial dose of atenolol is 2.5 mg (5 ml) injected intravenously over a 2.5 minute period (i.e. 1 mg/minute). (See also prescribing i Läs hela dokumentet